Percutaneous coronary intervention (PCI) is widely performed for patients with ischemic heart disease. Restenosis is one of the pivotal problems of PCI. Drug-eluting stents (DES) dramatically reduce the restenosis rate after initial stent implantation, and it would seem that this problem has been resolved, but it is not yet